470 related articles for article (PubMed ID: 26960815)
1. Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.
Sharma G; Goyal H; Thakur K; Raza K; Katare OP
Drug Deliv; 2016 Oct; 23(8):3135-3145. PubMed ID: 26960815
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs.
Caddeo C; Sales OD; Valenti D; Saurí AR; Fadda AM; Manconi M
Int J Pharm; 2013 Feb; 443(1-2):128-36. PubMed ID: 23299087
[TBL] [Abstract][Full Text] [Related]
3. Nanoemulsions as vehicles for transdermal delivery of aceclofenac.
Shakeel F; Baboota S; Ahuja A; Ali J; Aqil M; Shafiq S
AAPS PharmSciTech; 2007 Dec; 8(4):E104. PubMed ID: 18181525
[TBL] [Abstract][Full Text] [Related]
4. Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route.
Jain S; Patel N; Madan P; Lin S
Pharm Dev Technol; 2015 Jun; 20(4):473-89. PubMed ID: 24490793
[TBL] [Abstract][Full Text] [Related]
5. Vesicular carriers for dermal drug delivery.
Sinico C; Fadda AM
Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
[TBL] [Abstract][Full Text] [Related]
6. Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment.
Garg BJ; Garg NK; Beg S; Singh B; Katare OP
J Drug Target; 2016 Mar; 24(3):233-246. PubMed ID: 26267289
[TBL] [Abstract][Full Text] [Related]
7. Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment.
Abidin L; Mujeeb M; Imam SS; Aqil M; Khurana D
Drug Deliv; 2016; 23(3):1079-84. PubMed ID: 25116512
[TBL] [Abstract][Full Text] [Related]
8. Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes.
Ghanbarzadeh S; Arami S
Biomed Res Int; 2013; 2013():616810. PubMed ID: 23936825
[TBL] [Abstract][Full Text] [Related]
9. Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes.
Ascenso A; Raposo S; Batista C; Cardoso P; Mendes T; Praça FG; Bentley MV; Simões S
Int J Nanomedicine; 2015; 10():5837-51. PubMed ID: 26425085
[TBL] [Abstract][Full Text] [Related]
10. Systematic Development of Transethosomal Gel System of Piroxicam: Formulation Optimization, In Vitro Evaluation, and Ex Vivo Assessment.
Garg V; Singh H; Bhatia A; Raza K; Singh SK; Singh B; Beg S
AAPS PharmSciTech; 2017 Jan; 18(1):58-71. PubMed ID: 26868380
[TBL] [Abstract][Full Text] [Related]
11. Aceclofenac topical dosage forms: in vitro and in vivo characterization.
Dua K; Pabreja K; Ramana MV
Acta Pharm; 2010 Dec; 60(4):467-78. PubMed ID: 21169138
[TBL] [Abstract][Full Text] [Related]
12. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery.
El-Menshawe SF; Hussein AK
Pharm Dev Technol; 2013; 18(4):779-86. PubMed ID: 21913880
[TBL] [Abstract][Full Text] [Related]
13. Formulation and Characterization of Aceclofenac -Aloe vera Transemulgel.
Raju YP; Haritha K; Satyanarayana RP; Vandana KR; Bindu DT; Vinesha V; Chowdary VH
Curr Drug Deliv; 2015; 12(6):703-8. PubMed ID: 25751659
[TBL] [Abstract][Full Text] [Related]
14. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.
Manosroi A; Jantrawut P; Manosroi J
Int J Pharm; 2008 Aug; 360(1-2):156-63. PubMed ID: 18539416
[TBL] [Abstract][Full Text] [Related]
16. Topical Nano-Vesicular Spanlastics of Celecoxib: Enhanced Anti-Inflammatory Effect and Down-Regulation of TNF-α, NF-кB and COX-2 in Complete Freund's Adjuvant-Induced Arthritis Model in Rats.
Alaaeldin E; Abou-Taleb HA; Mohamad SA; Elrehany M; Gaber SS; Mansour HF
Int J Nanomedicine; 2021; 16():133-145. PubMed ID: 33447032
[TBL] [Abstract][Full Text] [Related]
17. Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation.
Nasr M; Mansour S; Mortada ND; El Shamy AA
AAPS PharmSciTech; 2008; 9(1):154-62. PubMed ID: 18446476
[TBL] [Abstract][Full Text] [Related]
18. Ethosomes and Transfersomes: Principles, Perspectives and Practices.
Garg V; Singh H; Bimbrawh S; Singh SK; Gulati M; Vaidya Y; Kaur P
Curr Drug Deliv; 2017; 14(5):613-633. PubMed ID: 27199229
[TBL] [Abstract][Full Text] [Related]
19. Selection of high efficient transdermal lipid vesicle for curcumin skin delivery.
Zhao YZ; Lu CT; Zhang Y; Xiao J; Zhao YP; Tian JL; Xu YY; Feng ZG; Xu CY
Int J Pharm; 2013 Sep; 454(1):302-9. PubMed ID: 23830940
[TBL] [Abstract][Full Text] [Related]
20. Statistically optimised ethosomes for transdermal delivery of tolterodine tartrate.
Prasanthi D; Lakshmi PK
Pak J Pharm Sci; 2013 Nov; 26(6):1117-22. PubMed ID: 24191315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]